Revvity Inc. (RVTY)
Pretax margin
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jul 5, 2020 | Apr 5, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | 696,567 | 818,800 | 889,150 | 1,064,614 | 708,340 | 845,531 | 902,669 | 1,004,733 | 1,267,381 | 1,425,846 | 1,504,447 | 1,343,204 | 897,399 | 498,383 | 327,865 | 234,862 | 236,947 | 251,098 | 267,040 | 266,365 |
Revenue (ttm) | US$ in thousands | 2,769,887 | 2,744,391 | 2,810,941 | 3,023,524 | 3,311,822 | 3,598,518 | 3,748,030 | 3,763,135 | 3,827,812 | 4,154,512 | 4,257,222 | 4,158,193 | 3,782,749 | 3,233,635 | 2,976,533 | 2,887,332 | 2,883,673 | 2,834,526 | 2,801,916 | 2,782,761 |
Pretax margin | 25.15% | 29.84% | 31.63% | 35.21% | 21.39% | 23.50% | 24.08% | 26.70% | 33.11% | 34.32% | 35.34% | 32.30% | 23.72% | 15.41% | 11.01% | 8.13% | 8.22% | 8.86% | 9.53% | 9.57% |
December 31, 2023 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $696,567K ÷ $2,769,887K
= 25.15%
Revvity Inc.'s pretax margin has exhibited a declining trend over the past eight quarters, from a high of 20.26% in Q1 2022 to 6.65% in Q4 2023. This indicates a decrease in the company's ability to generate profits before accounting for taxes. The company experienced a significant decrease in pretax margin in the most recent quarters, potentially signaling challenges in controlling costs or maintaining revenue growth. Further analysis would be necessary to understand the specific factors contributing to this decline and to assess the overall financial performance and efficiency of Revvity Inc.
Peer comparison
Dec 31, 2023
Company name
Symbol
Pretax margin
Revvity Inc.
RVTY
25.15%
Avantor Inc
AVTR
6.61%
Bio-Rad Laboratories Inc
BIO
-32.23%
Bruker Corporation
BRKR
18.38%
Cytek Biosciences Inc
CTKB
-8.14%
Illumina Inc
ILMN
-24.78%
Mettler-Toledo International Inc
MTD
25.70%
Waters Corporation
WAT
25.76%